Your browser doesn't support javascript.
loading
The survival significance of a measurable enhancing lesion after completing standard treatment for newly diagnosed glioblastoma.
Kim, Sung Kwon; Kim, Tae Min; Lee, Soon-Tae; Lee, Se-Hoon; Heo, Dae Seog; Kim, Il Han; Kim, Dong Gyu; Jung, Hee-Won; Choi, Seung Hong; Lee, Sang Hyung; Park, Chul-Kee.
Afiliación
  • Kim SK; Department of Neurosurgery, Gyeongsang National University School of Medicine, Changwon Gyeongsang National University Hospital, Changwon, South Korea.
  • Kim TM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Lee ST; Department of Neurology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea; Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea.
  • Lee SH; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Heo DS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Kim IH; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Kim DG; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea; Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea.
  • Jung HW; Department of Neurosurgery, Seoul National University College of Medicine, Seoul National University Hospital, 103 Daehak-ro, Jongno-gu, Seoul 03080, South Korea; Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea.
  • Choi SH; Department of Radiology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea; Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea.
  • Lee SH; Department of Neurosurgery, Seoul National University College of Medicine, Seoul National University Hospital, 103 Daehak-ro, Jongno-gu, Seoul 03080, South Korea; Department of Neurosurgery, Seoul National University Boramae Medical Center, Seoul, South Korea. Electronic address: nslee@snu.ac.kr.
  • Park CK; Department of Neurosurgery, Seoul National University College of Medicine, Seoul National University Hospital, 103 Daehak-ro, Jongno-gu, Seoul 03080, South Korea; Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea. Electronic address: nsckpark@snu.ac.kr.
J Clin Neurosci ; 34: 145-150, 2016 Dec.
Article en En | MEDLINE | ID: mdl-27475318

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Neurosci Asunto de la revista: NEUROLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Neurosci Asunto de la revista: NEUROLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Reino Unido